Welcome to LookChem.com Sign In|Join Free
  • or
4-Hydroxy-6,7-dimethoxyquinolin-2(1H)-one is a quinolinone derivative with the molecular formula C11H11NO4. It is characterized by the presence of hydroxy and dimethoxy functional groups attached to the quinoline ring, which contribute to its diverse biological activities. As a member of the quinolinone class, 4-Hydroxy-6,7-dimethoxyquinolin-2(1H)-one has been studied for its potential pharmacological properties, such as antioxidant and anti-inflammatory effects. Its unique structure and promising therapeutic potential make it an interesting candidate for further research and development in the pharmaceutical industry.

412335-39-8

Post Buying Request

412335-39-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

412335-39-8 Usage

Uses

Used in Pharmaceutical Industry:
4-Hydroxy-6,7-dimethoxyquinolin-2(1H)-one is used as a pharmaceutical candidate for its potential therapeutic applications due to its diverse biological activities. 4-Hydroxy-6,7-dimethoxyquinolin-2(1H)-one's antioxidant and anti-inflammatory properties make it a promising agent for the treatment of various diseases and conditions.
Used in Antioxidant Applications:
4-Hydroxy-6,7-dimethoxyquinolin-2(1H)-one is used as an antioxidant agent to protect cells from oxidative stress and damage. Its ability to neutralize free radicals and reduce oxidative stress makes it a potential candidate for the prevention and treatment of diseases associated with oxidative stress, such as neurodegenerative disorders and cardiovascular diseases.
Used in Anti-inflammatory Applications:
4-Hydroxy-6,7-dimethoxyquinolin-2(1H)-one is used as an anti-inflammatory agent to modulate the immune response and reduce inflammation. Its potential to inhibit inflammatory mediators and alleviate inflammatory processes makes it a promising compound for the treatment of inflammatory diseases, such as arthritis and autoimmune disorders.
Used in Drug Discovery and Development:
4-Hydroxy-6,7-dimethoxyquinolin-2(1H)-one is used as a lead compound in drug discovery and development efforts. Its unique structure and biological activities provide a foundation for the design and synthesis of novel therapeutic agents with improved pharmacological properties and targeted effects. Further research and development of 4-Hydroxy-6,7-dimethoxyquinolin-2(1H)-one may lead to the discovery of new drugs for the treatment of various diseases and conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 412335-39-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,1,2,3,3 and 5 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 412335-39:
(8*4)+(7*1)+(6*2)+(5*3)+(4*3)+(3*5)+(2*3)+(1*9)=108
108 % 10 = 8
So 412335-39-8 is a valid CAS Registry Number.

412335-39-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-hydroxy-6,7-dimethoxy-1H-quinolin-2-one

1.2 Other means of identification

Product number -
Other names S08-0137

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:412335-39-8 SDS

412335-39-8Relevant academic research and scientific papers

4-hydroxy-2-quinolones. 202*. Synthesis, chemical and biological properties of 4-hydroxy-6,7-dimethoxy-2-oxo-1,2-dihydroquinoline-3- carboxylic acid alkylamides

Ukrainets,Bevz,Mospanova,Savchenkova,Yankovich

, p. 320 - 326 (2012)

In continuation of the search for potential analgesics amongst 4-hydroxyquinol-2-one derivatives we have proposed and carried out a preparative method of synthesis of 4-hydroxy-6,7-dimethoxy-2-oxo-1,2-dihydroquinoline-3- carboxylic acid alkylamides. It has been shown that bromination of 4-hydroxy-6,7-dimethoxy-2-oxo-1,2-dihydroquinoline-3-carboxylic acid allylamide using an equivalent of molecular bromine occurs with a conventional addition of the halogen to the allyl double bond and not with halocyclization. The results of the study of the analgesic properties of the compounds prepared are presented.

Scaffold morphing leading to evolution of 2,4-diaminoquinolines and aminopyrazolopyrimidines as inhibitors of the ATP synthesis pathway

Tantry, Subramanyam J.,Shinde, Vikas,Balakrishnan, Gayathri,Markad, Shankar D.,Gupta, Amit K.,Bhat, Jyothi,Narayan, Ashwini,Raichurkar, Anandkumar,Jena, Lalit Kumar,Sharma, Sreevalli,Kumar, Naveen,Nanduri, Robert,Bharath, Sowmya,Reddy, Jitendar,Panduga, Vijender,Prabhakar,Kandaswamy, Karthikeyan,Kaur, Parvinder,Dinesh, Neela,Guptha, Supreeth,Saralaya, Ramanatha,Panda, Manoranjan,Rudrapatna, Suresh,Mallya, Meenakshi,Rubin, Harvey,Yano, Takahiro,Mdluili, Khisi,Cooper, Christopher B.,Balasubramanian,Sambandamurthy, Vasan K.,Ramachandran, Vasanthi,Shandil, Radha,Kavanagh, Stefan,Narayanan, Shridhar,Iyer, Pravin,Mukherjee, Kakoli,Hosagrahara, Vinayak P.,Solapure, Suresh,Hameed, P.Shahul,Ravishankar, Sudha

supporting information, p. 1022 - 1032 (2016/06/08)

The success of bedaquiline as an anti-tubercular agent for the treatment of multidrug-resistant tuberculosis has validated the ATP synthesis pathway and in particular ATP synthase as an attractive target. However, limitations associated with its use in the clinic and the drug-drug interactions with rifampicin have prompted research efforts towards identifying alternative ATP synthesis inhibitors with differentiated mechanisms of action. A biochemical assay was employed to screen AstraZeneca's corporate compound collection to identify the inhibitors of mycobacterial ATP synthesis. The high-throughput screening resulted in the identification of 2,4-diaminoquinazolines as inhibitors of the ATP synthesis pathway. A structure-activity relationship for the quinazolines was established and the knowledge was utilized to morph the quinazoline core into quinoline and pyrazolopyrimidine to expand the scope of chemical diversity. The morphed scaffolds exhibited a 10-fold improvement in enzyme potency and over 100-fold improvement in selectivity against inhibition of mammalian mitochondrial ATP synthesis. These novel compounds were bactericidal and demonstrated growth retardation of Mycobacterium tuberculosis in the acute mouse model of tuberculosis infection.

Syntheses and fluorescent properties of 6-methoxy-2-oxoquinoline-3,4- dicarbonitriles and 6,7-dimethoxy-2-oxoquinoline-3,4-dicarbonitriles

Enoua, Guy Crépin,Lahm, Günther,Uray, Georg,Stadlbauer, Wolfgang

, p. E263-E275 (2014/11/07)

4-Chlorocarbostyrils 3, 12, 17, 24, 26 with methoxy substituents in 6, 7, or 6,7-position react with potassium cyanide in a p-toluenesulfinate mediated reaction either to the highly fluorescent and stable 2-oxoquinoline-3,4- dicarbonitriles 6, 27, 29, 30 or at slightly lower temperatures to 4-monocarbonitriles 5, 13, 18. 4-Chlorocarbostyril 3 and lithium p-toluenesulfinate gave pure 4-toluenesulfonylquinolone 4, which reacted with potassium cyanide either to monocarbonitrile 5 or dicarbonitrile 6, depending on the reaction conditions. 4-Trifluoromethylquinolones 9 and 19 were prepared for fluorescence comparison from the appropriate methoxyaniline and 4,4,4-trifluoroacetoacetate. The fluorescence properties such as emission wavelengths and quantum yields of 6-methoxyderivatives 4, 5, 6, 9, 13 were studied and compared with those of 7-methoxy derivatives 18, 19 and 6,7-dimethoxyderivatives 27, 28, 29, 30. 6,7-Dimethoxy derivatives show best results, showing long-waved fluorescence spectra up to 520 nm and acceptable quantum yields up to 0.46 for 3,4-dicyano derivative 27 excited at 440 nm in acetonitrile.

4-Cyano-6,7-dimethoxycarbostyrils with solvent- and pH-independent high fluorescence quantum yields and emission maxima

Ahvale, Appasaheb B.,Prokopcova, Hana,Sefcovicova, Jana,Steinschifter, Waltraud,Taeubl, Anna E.,Uray, Georg,Stadlbauer, Wolfgang

, p. 563 - 571 (2008/09/18)

Highly fluorescent and stable 6,7-dimethoxy-2-oxoquinoline-4-carbonitriles (11) were synthesized starting from appropriate 4-hydroxyquinolones 3 via reactive 4-chloroquinolones 8 by using toluenesulfinates as catalysts. In contrast to the well-described 4-trifluoromethyl-substituted analogues 18, N-substituted derivatives 11 fluoresce in water, polar, and apolar solvents in a narrow 430-440-nm window with almost constant quantum yield of 0.5. Equal excitation is possible in the broad double maximum between 385 and 410 nm yielding identical data between pH 1 and 11. These properties could lead to a broadly usable fluorescence standard. N-Alkylation with bromoacetate yields ester 13 in good yields. Reactive succinimidoyl (OSu) ester 15 was prepared by saponification to acid 14. With amino acids or peptides, linking to labeled derivatives 17 was achieved under mild conditions in slightly basic aqueous media. Wiley-VCH Verlag GmbH & Co. KGaA, 2008.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 412335-39-8